P01   Factor V deficiency In Algeria: Single center experience
Moueden Mohamed Amine, Algeria
P02   Drug-immune thrombocytopenia with thrombosis versus heparin-induced thrombocytopenia: A critical clinical controversy
Hassan A. Al-Jafar, Kuwait
P03   Chemotherapy induced tumour microparticle release in vitro
Saeed Alqarni, UK
P04   Hemostatic changes in blood in post major orthopaedic surgery patients under the condition of low molecular weight heparin and tranexamic acid treatment
Irina Antropova, Russia
P05   Severe deficiency of Factor V: A case report in the perioperative setting
Ricard Mellado Artigas, Spain
P06   Comparison of the treatment outcome of anticoagulation versus catheter-directed thrombolysis with stenting for patients with May-Thurner Syndrome
Annamarie Pineda Borja, Singapore
P07   An improvement of score models in the prediction of Deep Vein Thrombosis of both upper and lower limbs in hospitalized patients
Antonella Maria Cardella, Italy
P08   Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in sickle cell disease thrombotic microangiopathies
Mingyi Chen, USA
P09   Predicting bleeding risk in patients on vitamin K antagonists treatment
Benlaldj Driss, Algeria
P10   Compound Factor V and Factor VIII deficiency in Algeria
Benlaldj Driss, Algeria
P11   Ultrasonic real-time monitoring of drug-induced fibrinolysis in blood flow
Shakhla Dzhumaeva, Russia
P12   Outcome of surgical intervention in patients with May-Thurner Syndrome
Chaozer Er, Singapore
P13   Venous thromboembolism occurence in 2 cases of stroke in the young: Is chronic antiplatelet prophylaxis enough?
Aissa Althea Flavier Hundal, Singapore
P14   ADAMTS-13 stable in citrated whole blood for 48 hours
Rebekah Fretwell, UK
P15   The retinal hemorrhage during fraxiparine treatment
Aleksandra Gergont, Poland
P16   Role of anticoagulation vs. anti-platelet in young patients with first episode of arterial thrombosis
Peiyan Ho, Singapore

A case of multiple arterial and venous thromboembolisms with chronic stage of SLE and occult lymphoma
Hatsue Ishibashi-Ueda, Japan

P18   Prothrombotic genetic variants and risk of premature idiopathic ischemic stroke
Rosa María Jiménez-Alvarado, Mexico
P19   Does prescribing mechanical Venous Thrombo Embolism (VTE) prophylaxis improve compliance with their use in surgical inpatients?
Parminder Kaur, UK
P20   FV-Leiden and FII-G20210 for spontaneous abortions. Physicians keep ask for the tests!
Theoni Kanellopoulou, Greece
P21   Screening women with miscarriages for MTHFR polymorphisms. Is there any clinical utility?
Theoni Kanellopoulou, Greece
P22   Combined heterozygosity for Factor V Leiden and Prothrombin G20210 mutation and recurrent venous thromboembolism. Should we suspect an additional risk factor?
Theoni Kanellopoulou, Greece
P23   Clinical and radiological features in patients with neuromyelitis optica and anti-phosphopolipid antibody syndrome: A case-series study
Kwang-Ho Lee, Korea
P24   Hemostatic potential in postoperatve patients with colon cancer
Iuliia Malysheva, Russia
P25   How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?
László Muszbek, Hungary
P26   Contribution of contact activation pathway to the hypercoagulable state in sickle cell disease
Rafal Pawlinski, USA
P27   Rivaroxaban to treat patients with gynecological cancer and venous thromboembolism at the Hospital of Cancer II /Inca-Brazil
Marcos Jose Pereira Renni, Brazil
P28   Venous thromboembolism risk and use of prophylaxis in chronically ill patients at home care
Ana Rocha, Brazil
P29   A forgotten enemy. Hemorheologic abnormalities as a cause thrombosis in some myeloproliferative neoplasms
Eugene Roitman, Russia
P30   Genetic risk factors for atherothrombotic disease in young individuals: Comparation between myocardial infarction and ischemic stroke
Irma Salas, Mexico
P31   Angiotensin-converting enzyme insertion/deletion and angiotensinogen M235T polymorphisms and the risk of idiopathic ischemic stroke in young individuals
Irma Isordia Salas, Mexico
P32   Congenital thrombotic thrombocytopenic purpura: New mutation. Case report
Hector Sarmiento, Spain
P33   Elevated Factor VIII levels in liver disease: Acute phase reactant or a marker of liver coagulopathy?
Priyanka Saxena, India
P34   Hemostatic alterations in patients with alcoholic cirrhosis-scenario from a developing country
Priyanka Saxena, India
P35   Drug resistant pulmonary embolism as a manifestation of choriocarcinoma
Anna Śniady, Poland

High prevalence of Glanzmann thrombasthenia at Almadinah, Saudi Arabia: A single center experience
Ahmad Tarawah, Saudi Arabia

P37   The impact of the using of oral coagulants on the incidence of colorectal cancer diagnoses: Single center experience
Jacek Zielinski, Poland
P38   Shear stress and Willebrand multimer length as control parameters of platelets activation
Ksenia Zlobina, Russia
P39   The impact of the metabolic syndrome on erythrocyte aggregation in Ischemic stroke patients
Marine Tanashyan, Russia
P40   Rheological and biochemical parameters of endothelial function at different degrees of carotid atherosclerosis in patients with Ischemic stroke
Marine Tanashyan, Russia